Core Viewpoint - Southbound funds have increased their holdings in Baize Medical (02609.HK), indicating growing investor interest in the company within the oncology healthcare sector [1] Group 1: Southbound Fund Activity - On January 28, southbound funds increased their holdings by 220,200 shares of Baize Medical [1] - Over the past 5 trading days, there have been 4 days of net increases, totaling 3,209,400 shares [1] - In the last 20 trading days, there were 14 days of net increases, amounting to 8,824,200 shares [1] - Currently, southbound funds hold 71,705,400 shares of Baize Medical, representing 5.42% of the company's total issued ordinary shares [1] Group 2: Company Overview - Baize Medical Group primarily engages in investment and provision of medical-related services, focusing on oncology [1] - The company offers comprehensive oncology services, including screening, diagnosis, treatment, and rehabilitation [1] - Its business operations encompass hospital services, hospital management, supply of pharmaceuticals, medical devices, consumables, and other related services [1] - The company also conducts early cancer screening, tumor vaccination, and health management services for potential healthy populations [1] - Baize Medical primarily operates in the Chinese market [1]
佰泽医疗（02609.HK）：1月28日南向资金增持22.02万股